HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tripathy, D. Articles by Groop, L. Search for Related Content PubMed PubMed Citation Articles by Tripathy, D. Articles by Groop, L. Social Bookmarking                What's this?

Contribution of Insulin-Stimulated Glucose Uptake and Basal Hepatic Insulin Sensitivity to Surrogate Measures of Insulin Sensitivity

¹ Department of Endocrinology, University Hospital MAS, Lund University, Malmö, Sweden
² Department of Medicine, Helsinki University Central Hospital, Folkhälsan Research Center and Research Program for Molecular Medicine, Helsinki University, Helsinki, Finland

Address correspondence and reprint requests to Leif Groop, MD, PhD, Department of Endocrinology, University Hospital MAS, Lund University, Malmö, S-20502 Sweden. E-mail: leif.groop{at}endo.mas.lu.se

OBJECTIVE—The goal of this study was to evaluate the performance of surrogate measures of insulin sensitivity and insulin secretion.

RESEARCH DESIGN AND METHODS—The homeostasis model assessment (HOMA) of insulin resistance (IR) and the insulin sensitivity index (S_i) from oral glucose tolerance test (OGTT) were compared with the M value from a hyperinsulinemic-euglycemic clamp in 467 subjects with various degrees of glucose tolerance. Endogenous glucose production (EGP) and hepatic insulin sensitivity were determined in a subset (n = 143). Insulin secretion was estimated as the HOMA ß-cell index and as the insulinogenic index from the first 30 min of the OGTT (I/G30) and compared with the first-phase insulin response (FPIR) to an intravenous glucose tolerance test (n = 218).

RESULTS—The M value correlated with the HOMA-IR (r = –0.591, P < 0.0001) and the S_i (r = 0.533, P < 0.0001) indexes in the total study group. HOMA-IR correlated with basal EGP in the total study group (r = 0.378, P < 0.0005) and in subjects with diabetes (r = 0.330, P = 0.01). However, neither HOMA-IR nor S_i correlated significantly with the M value in subjects with impaired fasting glucose (IFG) (r = –0.108, P = 0.5; r = 0.01, P = 0.9) or IFG/impaired glucose tolerance (IGT) (r = –0.167, P = 0.4; r = 0.09, P = 0.6). The HOMA-IR correlated with hepatic insulin sensitivity in the whole study group (r = –0.395, P < 0.005) as well as in the IFG/IGT subgroup (r = –0.634, P = 0.002) and in the diabetic subgroup (r = –0.348, P = 0.008). In subjects with IFG/IGT, hepatic insulin sensitivity was the most important determinant of HOMA-IR, explaining 40% of its variation. The HOMA ß-cell index showed a weak correlation with FPIR in the whole study group (r = 0.294, P = 0.001) but not in the subgroups. In contrast, the I/G30 correlated with FPIR in the whole study group (r = 0.472, P < 0.0005) and in the IFG/IGT subgroup (r = 0.493, P < 0.005).

CONCLUSIONS—HOMA-IR is dependent upon both peripheral and hepatic insulin sensitivity, the contribution of which differs between subjects with normal and elevated fasting glucose concentrations. These discrepancies develop as a consequence of a nonparallel deterioration of the variables included in the equations with worsening of glucose tolerance.

Abbreviations: EGP, endogenous glucose production • FPIR, first-phase insulin response • HOMA, homeostasis model assessment • IFG, impaired fasting glucose • IGT, impaired glucose tolerance • IR, insulin resistance • IVGTT, intravenous glucose tolerance test • I/G30, insulinogenic index from the first 30 min of the OGTT • NGT, normal glucose tolerance • OGTT, oral glucose tolerance test

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				L. Perreault, B. C. Bergman, M. C. Playdon, C. Dalla Man, C. Cobelli, and R. H. Eckel Impaired fasting glucose with or without impaired glucose tolerance: progressive or parallel states of prediabetes? Am J Physiol Endocrinol Metab, August 1, 2008; 295(2): E428 - E435. [Abstract] [Full Text] [PDF]

				A. O. Chavez, J. C. Lopez-Alvarenga, M. E. Tejero, C. Triplitt, R. A. Bastarrachea, A. Sriwijitkamol, P. Tantiwong, V. S. Voruganti, N. Musi, A. G. Comuzzie, et al. Physiological and Molecular Determinants of Insulin Action in the Baboon Diabetes, April 1, 2008; 57(4): 899 - 908. [Abstract] [Full Text] [PDF]

				H. Sourij, I. Schmoelzer, P. Dittrich, B. Paulweber, B. Iglseder, and T. C. Wascher Insulin Resistance as a Risk Factor for Carotid Atherosclerosis: A Comparison of the Homeostasis Model Assessment and the Short Insulin Tolerance Test Stroke, April 1, 2008; 39(4): 1349 - 1351. [Abstract] [Full Text] [PDF]

				W.-C. Hsueh, K. D. Silver, T. I. Pollin, C. J. Bell, J. R. O'Connell, B. D. Mitchell, and A. R. Shuldiner A Genome-Wide Linkage Scan of Insulin Level Derived Traits: The Amish Family Diabetes Study Diabetes, October 1, 2007; 56(10): 2643 - 2648. [Abstract] [Full Text] [PDF]

				G. Bock, E. Chittilapilly, R. Basu, G. Toffolo, C. Cobelli, V. Chandramouli, B. R. Landau, and R. A. Rizza Contribution of Hepatic and Extrahepatic Insulin Resistance to the Pathogenesis of Impaired Fasting Glucose: Role of Increased Rates of Gluconeogenesis Diabetes, June 1, 2007; 56(6): 1703 - 1711. [Abstract] [Full Text] [PDF]

				C. Beysen, E. J. Murphy, T. McLaughlin, T. Riiff, C. Lamendola, H. C. Turner, M. Awada, S. M. Turner, G. Reaven, and M. K. Hellerstein Whole-Body Glycolysis Measured by the Deuterated-Glucose Disposal Test Correlates Highly With Insulin Resistance In Vivo Diabetes Care, May 1, 2007; 30(5): 1143 - 1149. [Abstract] [Full Text] [PDF]

				D. W. Dunstan, J. Salmon, G. N. Healy, J. E. Shaw, D. Jolley, P. Z. Zimmet, N. Owen, and on behalf of the AusDiab Steering Committee Association of Television Viewing With Fasting and 2-h Postchallenge Plasma Glucose Levels in Adults Without Diagnosed Diabetes Diabetes Care, March 1, 2007; 30(3): 516 - 522. [Abstract] [Full Text] [PDF]

				E. Lin, L. S. Phillips, T. R. Ziegler, B. Schmotzer, K. Wu, L. H. Gu, L. Khaitan, S. A. Lynch, W. E. Torres, C. D. Smith, et al. Increases in Adiponectin Predict Improved Liver, but Not Peripheral, Insulin Sensitivity in Severely Obese Women During Weight Loss Diabetes, March 1, 2007; 56(3): 735 - 742. [Abstract] [Full Text] [PDF]

				N. Takashima, H. Tomoike, N. Iwai, C. Erikstrup, O. H. Mortensen, B. K. Pedersen, J. Oh, T. E. Graham, U. Smith, and B. B. Kahn Retinol-Binding Protein 4 and Insulin Resistance. N. Engl. J. Med., September 28, 2006; 355(13): 1392 - 1395. [Full Text] [PDF]

				M. A. Abdul-Ghani, D. Tripathy, and R. A. DeFronzo Contributions of {beta}-Cell Dysfunction and Insulin Resistance to the Pathogenesis of Impaired Glucose Tolerance and Impaired Fasting Glucose Diabetes Care, May 1, 2006; 29(5): 1130 - 1139. [Abstract] [Full Text] [PDF]

				X.-H. Yao, L. Chen, and B. L. G. Nyomba Adult rats prenatally exposed to ethanol have increased gluconeogenesis and impaired insulin response of hepatic gluconeogenic genes J Appl Physiol, February 1, 2006; 100(2): 642 - 648. [Abstract] [Full Text] [PDF]

				D. E Laaksonen, L. K Toppinen, K. S Juntunen, K. Autio, K.-H. Liukkonen, K. S Poutanen, L. Niskanen, and H. M Mykkanen Dietary carbohydrate modification enhances insulin secretion in persons with the metabolic syndrome Am. J. Clinical Nutrition, December 1, 2005; 82(6): 1218 - 1227. [Abstract] [Full Text] [PDF]

				M. H. Tan, A. Baksi, B. Krahulec, P. Kubalski, A. Stankiewicz, R. Urquhart, G. Edwards, D. Johns, and for the GLAL Study Group Comparison of Pioglitazone and Gliclazide in Sustaining Glycemic Control Over 2 Years in Patients With Type 2 Diabetes Diabetes Care, March 1, 2005; 28(3): 544 - 550. [Abstract] [Full Text] [PDF]